Rationale, aims and objectives To evaluate asthma management and control in primary care clinics so as to design improvements based on guideline-directed outcomes. Methods In this study, all medical records of asthma-diagnosed patients (children as well as adults, entire lifespan, asthma-related visits or not) were retrospectively reviewed as a basis for assessing the level of guideline adherence and asthma control. Six primary health care clinics were visited in the Dr Kenneth Kaunda Municipal District, Potchefstroom, South Africa during May to July 2008July , 2009July and 2010. Results A total of 323 asthma patient records were reviewed over the three time slots, resulting in 125, 87, and 111 patients respectively. A suboptimal clinical asthma control picture, with a mere 16% (n = 20) of females and 2% (n = 3) of males with Peak Expiratory Flow (PEF) percentages above 60%, were observed in the initial assessment. Improvement in control was observed during the following time slot, but with an end result in 2010 of no PEF percentages above 60% for males and only 9% (n = 7) for females. Conclusion Over all three of the data collection periods adherence to effectively applied management of asthma guidelines proved to be below the minimum recommended clinical evaluation work-up as set out by the Expert Panel Report 3 (EPR3) of the National Asthma Education and Prevention Program (NAEPP). Applying a greater focus on essential outcomes through different disease management documents resulted in an improved quality of managed care, but still requires dedicated and continuous education and motivation.
Introduction
Asthma poses a serious health problem worldwide [1, 2] and is continuously increasing in prevalence [3] [4] [5] . Health care systems and expenditures are heavily burdened by asthma, including pharmaceutical costs and work-or school-related unproductivity [6, 7] , especially due to uncontrolled asthma [8] . Several studies considered this problem together with the complex challenges of managing and controlling asthma as it can not be reduced to one single measurement or view [9] . Little attention has been devoted to the evaluation and implementation of more recent (2007) revised guidelines of the National Asthma Education and Prevention Program (NAEPP), the Expert Panel Report 3 (EPR-3) [10] , in primary care. These guidelines are designed to help with recognition of suboptimal asthma control and to improve the management of the disease. However, if various guideline-specific outcomes are adhered to, it can help to manage and control asthma. Successful practice guideline implementation can be measured by the ability to bring forth data that indicate health status improvement, based on or addressed by certain health recommendations [11, 12] . The improved 2007 NAEPP revised guideline-directed care outcomes can be used by health care providers (HCPs) as steps towards disease control and severity management, because a large number of the population of rural areas obtain medical treatment at primary health care clinics that are mainly staffed by nursing personnel. Table 1 summarizes these essential outcomes.
The ultimate goal of this study was to measure the outcomes after implementation of these guidelines in the primary care clinics of the Dr Kenneth Kaunda Municipal District (Potchefstroom), South Africa, and to supply useful retrospective health status data. 
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The aim was to improve the management and control of asthma, which could lead, after analysis of practical recommendations, to data useful for wider implementation in the treatment of asthma patients.
Methods and materials

Overview
For this three-stage, non-experimental, quantitative, repeated measures, descriptive-designed study, approved by the Ethics Committee of the North-West University (NWU-0052-08-A5), Department of Health (DOH) and local government administrators, key performance measures and documented compliance were reviewed and evaluated for applicability in the setting. This setting was derived from and inspired by national and international asthma diagnosis and management guidelines. These measured outcomes were indicators in different domains, that is, (1) physiological assessment of functional symptoms and signs that are pivotal to asthma management (night symptoms, tightness of chest or chest pain, shortness of breath, cough, wheezing); (2) patient follow-up; (3) probing of exposure to environmental asthma trigger factors contributing to asthma severity (smoke exposure, other illnesses or drugs); (4) patients' response to therapy (pulmonary function monitoring); and (5) drug monitoring (medication according to guidelines).
All patient selection and data collection of the study were non-randomized and were conducted in six of the eight clinics of Potchefstroom, a rural area, forming part of the Dr Kenneth Kaunda Municipal District in South Africa. The clinics were statistically pre-selected for the purpose of this study. In order to obtain a representative sample, two of the health care clinics were excluded, because they did not render 'extended hour services' as was done by the other selected clinics. All asthmatic patients that attended the selected clinics whether for asthmarelated conditions or not, were provided with the relevant study information (verbally by means of the HCP and in writing on the informed consent document) and were requested to voluntarily participate in the study. Candidates were also informed about their right to refuse participation or to withdraw at anytime during the study. A coding system protected each patient's identity.
Chart entries from the period 1 May 2008 to 31 July 2008 were reviewed solely by the principal investigator and used as baseline values.
Over the next year, a new checklist-format document, based on national and international asthma guidelines, was developed (e.g. Appendix A). The HCPs of these clinics were then, during an asthma workshop, instructed on how to implement this document.
A second analysis of the patient records of the clinics in which these HCPs worked (stage 2 -see Figure 1 ), based on the cliniccoded charts, took place from 1 May 2009 through 31 July 2009. Improvements were noticeable, although, overall asthma control was still unsatisfactory.
A third and final data collection period (stage 3 -see Figure 1 ) followed at the same clinics, repeating the process of the first two review activities. These dates, 1 May 2010-31 July 2010, thus were only one year later after the 1 May 2009-31 July 2009 data collection period.
Study population
Patients were included based on the inclusion and exclusion criteria determined for the study ( Table 2) .
The records of all asthma-diagnosed patients at six statistically verified pre-selected clinics of the Dr Kenneth Kaunda Municipal District (Potchefstroom), South Africa, with at least one clinic visit were analysed during the three 3-month intervals, set apart one year from each other (see Figure 1) . The number of patients that were included was restricted by the fact that no asthma clinic was held at these primary health care clinics, and HCPs were limited at times due to extreme workload. As a result, no patient's medical record for the principal investigator's 'study box' could be collected. The study population rendered asthma patients (n = 323) ranging from birth to death (3-81 years). The male to female ratio was 1:3.
Data collection
After approval for the study from the Ethics Committee of the North-West University, DOH and administrators of local clinics had been obtained, the study team searched for patients who had been diagnosed with asthma and who had had either asthmarelated or asthma-unrelated primary care clinic visits during the particular periods. These patients were fully informed about the study and agreed to participate. The HCPs obtained formal consent. Thereafter, the clinical notebooks were clinic coded to ensure nameless follow-up (e.g. PT1 represented patient number one from Potchefstroom's town clinic). Because there was no direct patient-researcher contact, and the patients could stay anonymous, none of them refused to participate.
With the administrative requirements completed, methodological research into essential fields of asthma outcomes followed, with analysis to refine the understanding of the quality of care of asthma management in the clinics. The 1-year interval between the data collections were used for an asthma workshop on health care provider education and the implementation of the newly designed asthma patient follow-up forms.
Statistical analyses
All data were collected by the principal investigator and then captured into a spreadsheet by an independent data-capturer. Report was done by means of useful, uncomplicated descriptive statistics (frequencies and means) for individual audits. Dependent t-tests and two-way frequency tables were used to determine improvements over time in the patients involved in all audits. Analyses were performed by using STATISTICA 9.0, StatSoft, Inc. (2009) (Southern Africa, Sandton), STATISTICA (data analysis software system), version 9.0, http://www.statsoft.com.
Results
Description of the study
Of the 323 patients involved in the study, 28% were male (n = 89). The mean age of the patients was 52 years (median = 54 years), with ages ranging between 3 and 81 years. Patient records, 125, 87 and 111 from the three data collection periods, respectively, were clinic coded for follow-up purposes.
Measured outcomes
During the course of this study two sets of interventions took place. The first set included a HCP workshop and the implemen- It was clear from the results of the study that early childhood detection and diagnosis of asthma was low. Only seven patients (2%) through all stages of the data collection were Յ12 years (the age boundary set by the new asthma guidelines for children). Adult diagnoses, whether correct or incorrect, were unsatisfactory in the first collection group, with a 26% rate of undocumented diagnoses, whereas the second collection group showed significant improvement with a mere 6% not documented. The last stage of the study had no educational support (workshop), and the undocumented diagnoses rose to 35%. were not implemented. According to Wechsler [13] , it is not only the fact that symptoms and their frequency do not feature on paper that therapy adjustments are overseen, but elements such as overestimation of control and/or symptom prevalence underestimation also play a role. Trigger factor assessment by means of smoking history of the patient, as well as that of people in the patient's near vicinity is important [14] . Therefore, the overall 44% documentation rate of smoking history is not good enough. Chalmers et al. [15] and Tomlinson et al. [16] pointed out that cigarette smoking does an injustice to the way asthmatic patients respond to inhaled corticosteroid (ICS) and that smokers on ICS therapy therefore required higher doses of treatment to be effective, but then, resulted in increased side effect risks. No evidence of dose adjustment could be found.
At the baseline (set at the first 2008 collection period -stage 1), the mean peak expiratory flow (PEF) percentage was 46, with the median = 47 and the range being 17-78. Age and sex variations can be viewed in Table 3 (Tables 4 & 5) .
A meagre 0.6% of well-controlled asthmatic patients (PEF Ն 80%) could be identified at the six selected clinics during the entire data collection period (stage 1 through stage 3).
An average of 80% of the total data population received dates for follow-up visits to come back (TCB). None of the initial patient records contained documentation or a copy of any existing asthma action/self-management plan as required by the guidelines, and there was no evidence of monitored inhaler techniques during any of the stages of data collection.
Looking at the medication management (pharmacotherapy) through the eye of the asthma guidelines, all asthmatic patients should receive an inhaled short-acting b 2 agonist such as salbutamol for symptom relief (as needed) and an ICS as baseline treatment (excluding mild intermittent asthma). If uncontrolled, in the primary health care setting, the ICS must be doubled and a slowrelease theophylline added. Oral corticosteroids as maintenance therapy must be prescribed with extreme caution. The study found that the prescribing rate of the combination baseline treatment (salbutamol and beclomathasone) for the overall data population was 84% (n = 271), while the triple therapy (theophylline added) featured around 60% (n = 195). If we look at the documented pulmonary functions that reached a level of more than 60%, a total of 50 patients (22% of the documented data population) could be found. This would imply that 78% most likely had severe chronic persistent asthma depending on their symptoms and needed to be on triple therapy. No evidence of ICS dose adjustment was depicted. Overall, the medication management did not reveal significant discrepancies, even if the use of oral corticosteroids were well managed (Table 6) .
One of the main reasons for not utilizing the newly recommended form (Appendix A) was confusion among the HCPs about using different forms for each chronic disease, as several asthmatic patients also had other chronic illnesses. This meant a separate document for each illness, which was not only time consuming, but also posed the problem of possible incomplete and inaccurate documentation. This complication drew attention to the need to design a standard combined chronic disease form (Appendix B). Appendix B shows the multiple disease management and control document, designed and reconstructed by the research team, with inputs from colleagues and all the HCPs of the involved clinics. The use of this document in the Dr Kenneth Kaunda Municipal District was approved for implementation as of April 2010.
Discussion
This study is, to our knowledge, one of the first conducted in Potchefstroom, an entity of the Dr Kenneth Kaunda Municipal District, South Africa, to address HCP knowledge about asthma, its triggers, clinical patient symptoms and control, and selfmanagement tools placing emphasis on written asthma action plans (documentation) and guideline adherence.
Care deficiencies were identified in all realms of care. Overall, only 15% of the patients demonstrated partly controlled asthma (PEF = 60-80%), with 0.6% of the patients reaching the wellcontrolled level (PEF Ն 80%), as stipulated by the 2007 updated guidelines for the diagnosis and management of asthma (the EPR-3) of the NAEPP [10] . The lack of, or incomplete information (e.g. no PEF monitoring documented or no age supplied to calculate the PEF percentage) regarding a patient's ongoing health situation limits the knowledge on which a HCP needs to base 74 (92) 94 (82) 65 (72) HT, hypertension; TCB, to come back, Dx, diagnosis.
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asthma management. In fact, undocumented outcomes, as seen in this study, leave gaps for unnoticed asthma symptom burdens and limited asthma control. Because management of patients can not feature without good tracking methods, such as regular patient follow-up visits and aided therapeutic decisions, the use of a monitoring document is of highest importance. Drs Tom James and Michael Fine [17] highlight the limitations of the use of retrospective and administrative claims data and the importance of careful symptom tracking to determine a patient's level of asthma control. They recommend a combination method for poorly controlled asthmatics. Therefore, the team recommended the use of a combined document that could not only serve as an asthma action plan but also monitor the patient as a person possibly suffering from additional chronic conditions other than asthma together with other therapy interactions.
The newly designed document (Appendix B) could render a more holistic view of a patient's overall condition, which in return would grant the HCP a clearer indication of the cause of the condition, for example, aggravation of condition. The design of outcomes management will assist in education and support on baseline establishment, progress documentation, goal setting and patient motivation, offering something to the 'patient, provider, and payer' [18] . This document then holds diagnostic and treatment benefits leading to a targeted management approach, for example, a chronic cough of an asthmatic patient might be aggravated by the use of some hypertensive drugs that can be easily detected on this one-page conclusive document.
Further improvement opportunities prevail in areas such as written action plans as self-management tools, optimizing PEF monitoring and proper history taking plus documentation thereof and providing patients with routine follow-up dates [19] . Selfmanagement tools in clinics ask for additional work to promote the use thereof [19] . Less than optimal asthma control can further be linked to poor adherence by both the HCP and the patient. No information was identified on patient response towards medication adjustments (asthma action plans) in the cases of uncontrolled or partly controlled asthma, and HCP responses were sparse. Precise, yet brisk assessment of patient therapy response and adherence should be assisted by a composite of contributing asthma control and quality of life patient-reported factors recorded by HCPs. These diverse aspects of control measurements need to be incorporated over time.
All the abovementioned factors contribute to achieving and maintaining asthma control, which again may exercise an impact on the patient's quality of life and costs around chronic disease control. This comes to prove the importance of guideline adherence by HCP and patient.
Guidelines, action plans and documentation are considered useful, but HCPs lack sufficient continuous education and documentation skills. The chronic disease management document that is based on the asthma management and control guidelines is particularly suitable because the HCP can now manage the patient as a person. With full access to all necessary patient information on one page (drugs, allergies, symptoms and control of all contingent illnesses), various patient management and control difficulties may come to light.
In our opinion, in Potchefstroom and South Africa, such a chronic disease management document (Appendix B) can be implemented as a standard tool to monitor patients in primary health care settings. Presently, however, there is a lack of dedication towards clinical notes and documentation. The guidelines are there and we have developed the instruments to improve asthma management and control, but continuous education as reminders on the completion of these forms must feature as reinforcement. PEF, peak expiratory flow. We feel that the concept is feasible and provides a platform for introducing quality of care in the primary health care environment.
Conclusion
The study demonstrates sufficient opportunities for improving the quality of care for asthma patients at managed primary health care
clinics. An asthma management document was developed, tested and considerably modified to render the easy-to-apply chronic disease management document. Each stage of the study has shown that a comprehensive approach through continuous education for HCPs and improved documentation skills may be necessary to address important care aspects through the refinement of guideline-defined essential outcomes.
